Plaque Psoriasis (Psoriasis Vulgaris) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 114 pages | ID: P56CA331CB1EN
VPAResearch

Abstracts

Plaque Psoriasis (Psoriasis Vulgaris) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Plaque Psoriasis (Psoriasis Vulgaris) disease clinical trials. The research work analyzes the ongoing Plaque Psoriasis (Psoriasis Vulgaris) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Plaque Psoriasis (Psoriasis Vulgaris) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Plaque Psoriasis (Psoriasis Vulgaris) clinical trials.

Scope of the Report-

• Ongoing Plaque Psoriasis (Psoriasis Vulgaris) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Plaque Psoriasis (Psoriasis Vulgaris)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Plaque Psoriasis (Psoriasis Vulgaris) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Plaque Psoriasis (Psoriasis Vulgaris) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Plaque Psoriasis (Psoriasis Vulgaris) Trials by Phase
3.2 Ongoing Plaque Psoriasis (Psoriasis Vulgaris) Trials by Type
3.3 Ongoing Plaque Psoriasis (Psoriasis Vulgaris) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Plaque Psoriasis (Psoriasis Vulgaris) Trials
4.2 Top 10 Countries conducting Plaque Psoriasis (Psoriasis Vulgaris) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Plaque Psoriasis (Psoriasis Vulgaris) Trials by Sponsor Type
5.2 Plaque Psoriasis (Psoriasis Vulgaris) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Plaque Psoriasis (Psoriasis Vulgaris) Trials by year
6.2 Subjects Recruited for Plaque Psoriasis (Psoriasis Vulgaris) Trials by Phase
6.3 Subjects Recruited for Plaque Psoriasis (Psoriasis Vulgaris) Trials by Trial Type
6.4 Subjects Recruited for Plaque Psoriasis (Psoriasis Vulgaris) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Plaque Psoriasis (Psoriasis Vulgaris) Trials- Phase
7.2 Ongoing Plaque Psoriasis (Psoriasis Vulgaris) Trials- Phase
7.3 Ongoing Plaque Psoriasis (Psoriasis Vulgaris) Trials- Phase
7.4 Ongoing Plaque Psoriasis (Psoriasis Vulgaris) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials by Country
Figure 2: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials by Phase of Development, 2018
Figure 3: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials by Status, 2018
Figure 4: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials by Type, 2018
Figure 5: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials Split by Region, 2000-2018
Figure 6: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials by Type of Economy, 2018
Figure 7: Plaque Psoriasis (Psoriasis Vulgaris)- Enrolment by Phase, 2018
Figure 8: Plaque Psoriasis (Psoriasis Vulgaris)- Enrolment by Trial Type, 2018
Figure 9: Plaque Psoriasis (Psoriasis Vulgaris)- Enrolment by Recruitment Status, 2018
Figure 10: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials by Sponsor Type, 2018
Figure 11: Plaque Psoriasis (Psoriasis Vulgaris)- Enrolment by Type of Sponsors
Figure 12: Plaque Psoriasis (Psoriasis Vulgaris)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials by Sponsor Type, 2018
Table 2: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials by Economy Type, 2018
Table 3: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials by Region, 2018
Table 4: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Plaque Psoriasis (Psoriasis Vulgaris)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Plaque Psoriasis (Psoriasis Vulgaris)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Plaque Psoriasis (Psoriasis Vulgaris)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Plaque Psoriasis (Psoriasis Vulgaris)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Plaque Psoriasis (Psoriasis Vulgaris)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company